ACME Laboratories Ltd 2020 AR2
The report for the fiscal year 2019-2020 highlights ACME Laboratories' commitment to the 'One Health' approach, integrating human, animal, and environmental health. Despite the COVID-19 pandemic, the company achieved a revenue growth of 16.53%, reaching BDT 19,003.66 million, and expanded its global footprint by launching products in the US and UK markets. Sustainability efforts included recycling 540,000 liters of water daily through an Effluent Treatment Plant and transitioning to HFA-based inhalers to reduce CFC usage. The company also actively supported national COVID-19 mitigation efforts by providing PPE and emergency medicines.
Company: ACME Laboratories Ltd
Sector: Manufacturing
Country: Bangladesh
Year: 2020
Type: AR2
Pages: 171
ACME Laboratories Ltd
The report for the fiscal year 2019-2020 highlights ACME Laboratories' commitment to the 'One Health' approach, integrating human, animal, and environmental health. Despite the COVID-19 pandemic, the company achieved a revenue growth of 16.53%, reaching BDT 19,003.66 million, and expanded its global footprint by launching products in the US and UK markets. Sustainability efforts included recycling 540,000 liters of water daily through an Effluent Treatment Plant and transitioning to HFA-based inhalers to reduce CFC usage. The company also actively supported national COVID-19 mitigation efforts by providing PPE and emergency medicines.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jul 1, 2019 - Jun 30, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees